MEI Pharma (LTS:0JW9) 3-Year Book Growth Rate : -17.40% (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is MEI Pharma 3-Year Book Growth Rate?

MEI Pharma's Book Value per Share for the quarter that ended in Dec. 2024 was $3.32.

During the past 12 months, MEI Pharma's average Book Value per Share Growth Rate was -62.80% per year. During the past 3 years, the average Book Value per Share Growth Rate was -17.40% per year. During the past 5 years, the average Book Value per Share Growth Rate was -22.50% per year. During the past 10 years, the average Book Value per Share Growth Rate was -20.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of MEI Pharma was 20.00% per year. The lowest was -56.30% per year. And the median was -16.55% per year.

Competitive Comparison of MEI Pharma's 3-Year Book Growth Rate

For the Biotechnology subindustry, MEI Pharma's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MEI Pharma's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MEI Pharma's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where MEI Pharma's 3-Year Book Growth Rate falls into.

MEI Pharma 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

MEI Pharma (LTS:0JW9) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

MEI Pharma 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of MEI Pharma's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

MEI Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MEI Pharma Inc (LTS:0JW9) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

MEIP:USA

Address

9920 Pacific Heights Blvd, Suite 150, San Diego, CA, USA, 92121

Website

https://www.meipharma.com

MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.

MEI Pharma Headlines

No Headlines